Equipment Monitoring – Ensuring Security, Efficiency and Compliance
Ultimately, good quality results rely on lab equipment being efficient at what they do but with constant developments of new technologies, changing regulations and standards, it’s often overwhelming to keep pace.
How Scalable Genome Engineering Can Improve Results With an Automated Workflow
Download this eBook to discover an automated benchtop system that can be easily integrated into established workflows and allows you to design, engineer, evaluate and track editing results.
The Scientific Observer Issue 04 July 2021
Download this month's issue of The Scientific Observer to learn more about scientific storytelling, the ethical complexities surrounding neurotechnology and more.
Exploring the Roles of β-Arrestins and Their Therapeutic Potential in GPCR Signaling
Download this eBook to learn more about β-arrestin research and drug discovery.
Uncover New Drug Targets Through Cell Metabolism
Drug target identification is a key step in the discovery and development of safe and effective therapies. Energy metabolism is now emerging as a critical contributor to many cellular functions.
Advances in Proteomics and Peptide Quantification Using LC-MS
Download this free eBook to explore how LC-MS is advancing proteomics and peptide quantification.
Uncovering the Complexity of Infectious Diseases with Single Cell and Spatial Multiomics
Download this eBook to learn more about the single cell and spatial technologies available for infectious disease research.
Mass Spectrometry Applications
In this eBook, we provide an overview of how a mass spectrometer works and highlight some of the ways the technique is currently being applied.
The Scientific Observer Issue 03 June 2021
Download this month's issue of The Scientific Observer to learn about life as a "long-hauler", the impact of impostor syndrome in STEMM and the latest updates from the newsroom.
Personalized Medicine – In Vitro Drug Testing on Primary Cancer Cells
Download this eBook to learn more about identifying new treatments, using in vitro and in vivo models for drug screening as well as predicting patient drug responses to cancer organoids.